Franklin Biotechnology Discovery Fund A(acc)USD
Equity fund
1 year
USA
Largest region
High
Risk
Annual costs
Morningstar
Partial
Sustainability
Development
Last 5 years
( ann.)
Description
- Fondet investerer hovedsakelig i aksjeverdipapirer utstedt av bioteknologiselskaper av enhver størrelse , og som befinner seg i USA og i andre land Fondet kan investere i mindre omfang i gjeldsobligasjoner av høyere kvalitet utstedt av selskaper Et bioteknologiselskap er et selskap som har minst 50 % av sitt overskudd fra eller er involvert i virksomheter som forskning, utvikling, produksjon og distribusjon av ulike bioteknologiske eller biomedisinske produkter, tjenester og prosesser. Fondet vil normalt investere mer i USA enn i noe annet land.
Investment horizon
- Franklin Biotechnology Discovery Fund A(acc)USD is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- Price/NAV
09 Sept 2025
- Start date02 Apr 2000
- ISINLU0109394709
Risk
- High (5 of 7)
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityPartial
Annual cost
- Ongoing costs
Includes management fees of 1,50 %
- Platform fee
- Kickback fee
- Annual running costs
Other costs
- Performance-based fee
- Transaction costs
Costs for any currency exchanges are not included.
Allocation
- Stocks 95%Interest 5%
Portfolio
Shows the fund's largest investments.
- Gilead Sciences Inc7.1%
- Amgen Inc5.4%
- Vertex Pharmaceuticals Inc5.3%
- Alnylam Pharmaceuticals Inc4.5%
- argenx SE ADR4.5%
- Regeneron Pharmaceuticals Inc4.4%
- Insmed Inc4.1%
- Jazz Pharmaceuticals PLC4.0%
- Ascendis Pharma AS ADR3.5%
- Merus NV2.9%